Mechanism of trastuzumab resistance caused by HER-2 mutation in breast carcinomas

Background: Trastuzumab is an effective drug for the treatment of Her2-positive breast cancer. But, primary or secondary resistances to trastuzumab have become an important factor influencing the curative effect. The mechanisms of trastuzumab resistance are somewhat complex. The present work aims to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xiangyi, Zhang, Kai, Wang, Xiangyu, Yang, Xue, Li, Yalun, Zhai, Jie, Xing, Zeyu, Qi, Yihang, Gao, Ran, Feng, Xiaoli, Wang, Jing, Fang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618040/
https://www.ncbi.nlm.nih.gov/pubmed/31308740
http://dx.doi.org/10.2147/CMAR.S194137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618040/
https://www.ncbi.nlm.nih.gov/pubmed/31308740
http://dx.doi.org/10.2147/CMAR.S194137

Ejemplares similares